152 related articles for article (PubMed ID: 38734641)
1. Interlukin-22 improves ovarian function in polycystic ovary syndrome independent of metabolic regulation: a mouse-based experimental study.
Chen W; Liao B; Yun C; Zhao M; Pang Y
J Ovarian Res; 2024 May; 17(1):100. PubMed ID: 38734641
[TBL] [Abstract][Full Text] [Related]
2. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
3. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
4. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome.
Zhang C; Ma J; Wang W; Sun Y; Sun K
Hum Reprod; 2018 Nov; 33(11):2096-2106. PubMed ID: 30272163
[TBL] [Abstract][Full Text] [Related]
6. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
[TBL] [Abstract][Full Text] [Related]
7. Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development.
Liao B; Qi X; Yun C; Qiao J; Pang Y
Front Endocrinol (Lausanne); 2022; 13():815968. PubMed ID: 35237237
[TBL] [Abstract][Full Text] [Related]
8. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.
Abramovich D; Irusta G; Bas D; Cataldi NI; Parborell F; Tesone M
Endocrinology; 2012 Jul; 153(7):3446-56. PubMed ID: 22577112
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome.
Li Y; Zheng Q; Sun D; Cui X; Chen S; Bulbul A; Liu S; Yan Q
J Cell Physiol; 2019 May; 234(5):7435-7447. PubMed ID: 30580448
[TBL] [Abstract][Full Text] [Related]
11. Role of EGFR expressed on the granulosa cells in the pathogenesis of polycystic ovarian syndrome.
Zhang JH; Zhan L; Zhao MY; Wang JJ; Xie FF; Xu ZY; Xu Q; Cao YX; Liu QW
Front Endocrinol (Lausanne); 2022; 13():971564. PubMed ID: 36440230
[TBL] [Abstract][Full Text] [Related]
12. The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways.
Ye Y; Zhou W; Ren Y; Lu J; Chen A; Jin R; Xuan F
Gynecol Endocrinol; 2023 Dec; 39(1):2254848. PubMed ID: 37706434
[TBL] [Abstract][Full Text] [Related]
13. IL-15 Participates in the Pathogenesis of Polycystic Ovary Syndrome by Affecting the Activity of Granulosa Cells.
Liu Y; Li Z; Wang Y; Cai Q; Liu H; Xu C; Zhang F
Front Endocrinol (Lausanne); 2022; 13():787876. PubMed ID: 35250857
[TBL] [Abstract][Full Text] [Related]
14. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.
Zhang H; Zheng L; Li C; Jing J; Li Z; Sun S; Xue T; Zhang K; Xue M; Cao C; Ouyang L; Qian Z; Xu R; He Z; Ma R; Chen L; Yao B
J Ovarian Res; 2023 Jul; 16(1):138. PubMed ID: 37443082
[TBL] [Abstract][Full Text] [Related]
15. Dietary Glycotoxins, Advanced Glycation End Products, Inhibit Cell Proliferation and Progesterone Secretion in Ovarian Granulosa Cells and Mimic PCOS-like Symptoms.
Lin PH; Chang CC; Wu KH; Shih CK; Chiang W; Chen HY; Shih YH; Wang KL; Hong YH; Shieh TM; Hsia SM
Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31370285
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes.
Wu H; Zhao B; Yao Q; Kang J
J Ovarian Res; 2023 Oct; 16(1):207. PubMed ID: 37880784
[TBL] [Abstract][Full Text] [Related]
17. RHOG-DOCK1-RAC1 Signaling Axis Is Perturbed in DHEA-Induced Polycystic Ovary in Rat Model.
Ubba V; Soni UK; Chadchan S; Maurya VK; Kumar V; Maurya R; Chaturvedi H; Singh R; Dwivedi A; Jha RK
Reprod Sci; 2017 May; 24(5):738-752. PubMed ID: 27662902
[TBL] [Abstract][Full Text] [Related]
18.
Luo M; Chen Y; Pan X; Chen H; Fan L; Wen Y
Front Immunol; 2023; 14():1137089. PubMed ID: 37275915
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic effect of interleukin-22 in high androgen-induced polycystic ovary syndrome.
Qi X; Yun C; Liao B; Qiao J; Pang Y
J Endocrinol; 2020 May; 245(2):281-289. PubMed ID: 32163914
[TBL] [Abstract][Full Text] [Related]
20. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
